Search

Jay Reilly represents biotech, medical device and diagnostic companies, as well as universities and nonprofits, in strategic transactions in the life sciences industry, particularly complex collaborative arrangements and technology acquisitions and dispositions. Jay has extensive experience...

A patent attorney with a Ph.D. in Molecular Biology and Microbiology, Alireza Behrooz assists companies and universities in protecting intellectual property connected to inventions in the life sciences. Drawing on years of private practice experience, Alireza prepares, files and secures patents as...

George Apostolides is a business and bankruptcy litigator who advises clients in the life sciences, cannabis, higher education, manufacturing, retail and technology industries. Drawing on over 25 years of experience, George handles cases in federal and state courts both in Illinois and nationwide...

Candice Kline advises clients on bankruptcy and corporate restructuring matters and related litigation. She represents debtors, trustees, official committees, investors and creditors in bankruptcy proceedings and out-of-court workouts. Her experience includes managing cases from $10 million to $13...

Steve Kerbaugh represents companies in employment and commercial litigation, and advises them on employment matters affecting their daily operations. Clients who look to him for advice range from closely held companies to multi-national, publicly traded corporations across the country and in an...

Max Bremer advises entrepreneurs and established companies on key transactions throughout the business life cycle, from formations and financings to mergers, acquisitions and divestitures. Max works with clients in a variety of industries, including health care IT, medical devices, data analytics...

Counsel From the Earliest Stage of Development Through Disposition of Projects Throughout the continuum of financing, acquiring, developing, leasing and selling real estate are a multitude of complexities to address and challenges to overcome—from regulatory hurdles and shifting capital stacks to...